UnitedHealth Group (NYSE:UNH) Trading 1.2% Higher After Analyst Upgrade

UnitedHealth Group Incorporated (NYSE:UNH) traded up 1.2% during mid-day trading on Thursday after Raymond James Financial upgraded the stock from a market perform rating to an outperform rating. Raymond James Financial now has a $330.00 price target on the stock. UnitedHealth Group traded as high as $279.04 and last traded at $277.3040. 6,372,653 shares traded hands during mid-day trading, a decline of 34% from the average session volume of 9,692,479 shares. The stock had previously closed at $273.98.

UNH has been the topic of several other reports. UBS Group dropped their target price on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating on the stock in a research report on Wednesday, January 28th. Oppenheimer dropped their price objective on shares of UnitedHealth Group from $415.00 to $385.00 and set an “outperform” rating on the stock in a report on Wednesday, January 28th. KeyCorp reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. Morgan Stanley dropped their price target on shares of UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating on the stock in a research note on Friday, January 23rd. Finally, Wells Fargo & Company decreased their price objective on UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating for the company in a report on Friday, January 30th. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $363.38.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Raymond James upgraded UNH to Outperform and set a $330 target, citing greater-than-expected expense/margin upside (particularly at Optum Health) and potential earnings upside over the next few years. Why Raymond James Says Wall Street Is Underestimating UnitedHealth’s Earnings Power
• Positive Sentiment: Zacks highlights UnitedHealth’s strong earnings‑surprise history and says the company has the setup to beat estimates again, supporting near‑term upside if execution continues. Will UnitedHealth (UNH) Beat Estimates Again?
• Positive Sentiment: Contrarian analysts and coverage (e.g., Investopedia) argue the sharp multi-quarter pullback has created a buying opportunity, noting attractive forward multiples and potential for a rebound. That narrative is drawing value‑focused buyers. UnitedHealth Stock: This Analyst Says It’s Time to Buy
• Neutral Sentiment: Analyst coverage is mixed but tilted positive: multiple firms maintain buy/outperform ratings and median price targets remain well above the current price (median ~$385), while institutional rebalancing has produced both large buys and large sells. UNH Opinions on Plunge Below Buffett Purchase Price
• Negative Sentiment: Leerink warns UNH faces its largest RADV (risk‑adjustment) audit exposure, a regulatory/audit risk that could pressure future margins and create earnings uncertainty. Leerink Sees Largest RADV Audit Exposure
• Negative Sentiment: Market chatter and coverage note sizable YTD declines and regulatory/Medicare rate worries; social media and fund flows highlight investor concern after shares fell below high‑profile purchase levels, keeping volatility high. Is UnitedHealth Now A Potential Opportunity?

Institutional Investors Weigh In On UnitedHealth Group

A number of institutional investors have recently added to or reduced their stakes in UNH. Sarver Vrooman Wealth Advisors acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at $25,000. Beacon Financial Strategies CORP acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $26,000. Anfield Capital Management LLC grew its stake in shares of UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after purchasing an additional 55 shares during the last quarter. Joseph Group Capital Management bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $27,000. Finally, Nalls Sherbakoff Group LLC bought a new stake in UnitedHealth Group during the fourth quarter worth approximately $27,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

The company has a market cap of $251.70 billion, a P/E ratio of 21.02, a PEG ratio of 1.26 and a beta of 0.40. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79. The company has a fifty day simple moving average of $284.61 and a 200-day simple moving average of $320.40.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business had revenue of $113.73 billion for the quarter, compared to analysts’ expectations of $113.38 billion. During the same period in the previous year, the firm posted $6.81 EPS. The company’s quarterly revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 3.2%. The ex-dividend date of this dividend was Monday, March 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 67.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.